Epilincomycin | CAS No. 17017-22-0

Epilincomycin

Basic Information

View in Editor

CAS Number

17017-22-0

Molecular Formula

C18H34N2O6S

Molecular Weight

406.5 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Surfactants Anionic Surfactants

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

Solubility

H2O: 50 mg/mL, clear, colorless

SMILES

View in Editor

CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)O

InChI

InChI=1S/C18H34N2O6S/c1-5-6-10-7-11(20(3)8-10)17(25)19-12(9(2)21)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,21-24H,5-8H2,1-4H3,(H,19,25)/t9-,10+,11-,12+,13-,14+,15+,16+,18+/m0/s1

InChIKey

OJMMVQQUTAEWLP-AWPVFWJPSA-N

LogP

-0.8569999999999969

Topological Polar Surface Area

122.49000000000002 Å²

Hydrogen Bond Donor/Acceptor

5 / 8

Complexity

499

Synonyms & References

English

CLINDAMYCIN HYDROCHLORIDE IMPURITY D [EP IMPURITY]
17017-22-0
Epilincomycin
LINCOMYCIN HYDROCHLORIDE IMPURITY D [EP IMPURITY]
Methyl 6,8-dideoxy-6-((((2S,4R)-1-methyl-4-propylpyrrolidin-2-yl)carbonyl)amino)-1-thio-L-threo-alpha-D-galacto-octopyranoside
Clindamycin hydrochloride impurity D [EP]
L-THREO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE, METHYL 6,8-DIDEOXY-6-((((2S,4R)-1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-THIO-
UNII-2C68Y244DD
(2S,4R)-N-[(1R,2S)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
METHYL 6,8-DIDEOXY-6-((((2S,4R)-1-METHYL-4-PROPYLPYRROLIDIN-2-YL)CARBONYL)AMINO)-1-THIO-L-THREO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE
7-Epilincomycin
(2S,4R)-N-((1R,2S)-2-Hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide
(2S,4R)-N-[(1R,2S)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
L-Threo-alpha-D-galacto-octopyranoside, methyl 6,8-dideoxy-6-((((2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-
(7S)-Lincomycin
2C68Y244DD
U 20244E
7-EPI-LINCOMYCIN
LINCOMYCIN
N-[2-HYDROXY-1-(3,4,5-TRIHYDROXY-6-METHYLSULFANYL-OXAN-2-YL)-PROPYL]-1-METHYL-4-PROPYL-PYRROLIDINE-2-CARBOXAMIDE
U-10149A
lincomyicin
Methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-D-erythro-alpha-D-gluco-octopyranoside
LINCOMYCIN HYDROCHLORIDE
7-EPI LINCOMYCIN
LINCOMYCIN HCL
Methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio- L-threo-alpha-D-galacto-Octopyranoside
LINCOMYCI
LINCOCIN HYDROCHLORIDE
7-EpilincoMycin (free base)
METHYL 6,8-DIDEOXY-6-(1-METHYL-4-PROPYL-2-PYRROLIDINECARBOXAMIDO)-1-THIO-D-ERYTHRO-ALPHA-D-GALACTOOCTOPYRANOSIDE HYDROCHLORIDE

MDL Number

MFCD25541734

FAQ

What regulatory guidelines apply to Epilincomycin (CAS: 17017-22-0)?

Epilincomycin (CAS: 17017-22-0) is subject to various regulatory guidelines depending on its intended use. In the European Union, it must comply with REACH regulations, which include registration, evaluation, authorization, and restriction of chemicals. Additionally, it must adhere to GHS (Globally Harmonized System of Classification and Labeling of Chemicals) for hazard communication. For FDA and EPA requirements in the United States, it must meet specific labeling, reporting, and registration standards for pharmaceutical and environmental safety.

Are there alternatives to Epilincomycin (CAS: 17017-22-0) in synthesis?

Yes, there are alternatives to Epilincomycin (CAS: 17017-22-0) in synthesis. Common substitutes include other lincosamide antibiotics such as clindamycin, which can serve similar therapeutic purposes. Researchers may also explore analogs and isomers that offer enhanced properties or reduced side effects. The choice of alternative reagents often depends on the specific application, such as antimicrobial efficacy, drug resistance, and pharmacokinetic properties.

What is the market or research trend for Epilincomycin (CAS: 17017-22-0)?

The market for Epilincomycin (CAS: 17017-22-0) is currently stable, with increasing interest in lincosamide antibiotics due to their spectrum of activity against a wide range of gram-positive bacteria. Research trends are focused on understanding its mechanism of action, exploring new formulations, and developing resistance management strategies. Additionally, there is ongoing investigation into its potential applications in combination therapies and as a treatment option for resistant infections.

How should waste containing Epilincomycin (CAS: 17017-22-0) be handled?

Waste containing Epilincomycin (CAS: 17017-22-0) should be handled according to environmental protection standards. Waste liquids should be collected in appropriate containers and disposed of through a professional waste disposal service. Incineration is a common method for disposing of such waste, ensuring complete destruction of the compound. Proper precautions should be taken to avoid environmental contamination, and regulatory requirements for hazardous waste disposal, such as those from the EPA, should be strictly followed.